Vanderbilt consortium receives award to use AI-enhanced technology to target motor neuron diseases

“Vanderbilt NeuroCline, a consortium of researchers from Vanderbilt Health and Vanderbilt University, has received a prestigious award to explore using artificial intelligence to find new drug targets for amyotrophic lateral sclerosis (ALS), the most common form of motor neuron disease.

Summary generated from the RSS feed of Vanderbilt News. All article rights belong to the original publisher. Click through to read the full piece on news.vanderbilt.edu.